The Medicines Company (leipzig) Gmbh

Andreas Van De Locht

Torsten Steinmetzer

Andrea Schweinitz

Claudia Reichelt

Alexander Schulze

Joerg Stuerzebecher

Friedrich-Alexander Ludwig

Jochen Heinicke

Peter Steinmetzer

Anett Soeffing

Silke Nicklisch

Mohammed Daghish

Mohammed Daghisch

The invention relates to inhibitors of trypsin-like serine proteases, including those of the general formula (IV) which, as well as plasmin, also inhibit plasma kallikrien, and to their use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive.

Trypsin-like serine protease inhibitors, and their preparation and use

The invention relates to inhibitors of trypsin-like serine proteases of the general formula (I) which, as well as plasmin, also inhibit plasma kallikrein, and to their preparation and use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive.

The invention relates to inhibitors of trypsin-like serine proteases of the general formula (I) which, as well as plasmin, also inhibit plasma kallikrien, and to their preparation and use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive.

Growing community of inventors

Munich, Germany

Andreas Van De Locht